TR201201022A2 - Pharmaceutical compositions for use in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections. - Google Patents

Pharmaceutical compositions for use in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections.

Info

Publication number
TR201201022A2
TR201201022A2 TR2012/01022A TR201201022A TR201201022A2 TR 201201022 A2 TR201201022 A2 TR 201201022A2 TR 2012/01022 A TR2012/01022 A TR 2012/01022A TR 201201022 A TR201201022 A TR 201201022A TR 201201022 A2 TR201201022 A2 TR 201201022A2
Authority
TR
Turkey
Prior art keywords
diseases
symptomatic
pharmaceutical compositions
therapeutic treatment
various infections
Prior art date
Application number
TR2012/01022A
Other languages
Turkish (tr)
Inventor
Karaağaç Bülent
Original Assignee
Karaağaç Bülent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karaağaç Bülent filed Critical Karaağaç Bülent
Priority to TR2012/01022A priority Critical patent/TR201201022A2/en
Publication of TR201201022A2 publication Critical patent/TR201201022A2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş; akciğer hastalıkları, karaciğer hastalıkları ve çeşitli enfeksiyonların semptomatik ve/veya terapötik tedavisinde farmasötik olarak kabul edilebilir bir mukolitik ajanın monoterapi olarak tek başına kullanıldığı veya bu mukolitik ajanın diğer uygun aktif ajan/lar ile kombine tedavi olarak kullanıldığı farmasötik bileşimler ile ilgilidir.The present invention includes; The present invention relates to pharmaceutical compositions in which a pharmaceutically acceptable mucolytic agent is used alone as monotherapy or in combination therapy with other suitable active agents / s in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections.

TR2012/01022A 2012-01-27 2012-01-27 Pharmaceutical compositions for use in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections. TR201201022A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/01022A TR201201022A2 (en) 2012-01-27 2012-01-27 Pharmaceutical compositions for use in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2012/01022A TR201201022A2 (en) 2012-01-27 2012-01-27 Pharmaceutical compositions for use in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections.

Publications (1)

Publication Number Publication Date
TR201201022A2 true TR201201022A2 (en) 2012-10-22

Family

ID=47679283

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/01022A TR201201022A2 (en) 2012-01-27 2012-01-27 Pharmaceutical compositions for use in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections.

Country Status (1)

Country Link
TR (1) TR201201022A2 (en)

Similar Documents

Publication Publication Date Title
CU20150163A7 (en) DERIVATIVES OF 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO (3,4-c) PIRAZOL-6-ONA ACTIVE AS BET INHIBITORS
EA201590343A1 (en) ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
BR112015012197A8 (en) cdk mtor inhibitor uses, and pharmaceutical combination comprising the same
EA201591363A1 (en) TIADIAZOLE ANALOGUES AND METHODS OF TREATMENT OF STATES ASSOCIATED WITH SMN DEFICIENCY
BR112015011171A2 (en) pyrrolopyrimidine compounds as kinase inhibitors
EA202092456A2 (en) COMBINATION THERAPY INCLUDING MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR TREATMENT OF VARIOUS TYPES OF CANCER
BR112015007366A2 (en) acylaminopyrimidine derivatives for the treatment of viral infections and other diseases
EA201490254A1 (en) COMBINED TREATMENT OF HEPATITIS C
BR112015024411A2 (en) macrocyclic desaza purinones for the treatment of viral infections
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
BR112015029491A2 (en) imidazopyrrolidinone derivatives and their use in the treatment of disease
EA201492290A1 (en) COMPOSITIONS AND METHODS FOR VAGINAL DELIVERY OF ANTIPROGHESTINES
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
NZ708016A (en) Lyophilized preparations of melphalan flufenamide
BR112016004358A8 (en) pharmaceutical combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases, pharmaceutical composition, their uses, and kit
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
BR112015029894A2 (en) solid pharmaceutical dosage form
BR112019007863A2 (en) innovative naphthyridinone derivatives and their use in the treatment of arrhythmia
MX2013001279A (en) Pharmaceutical composition with a selective enzyme phosphodiesterase inhibitor in an oral gel form.
BR112015019524A2 (en) combination treatment
BR112015028890A2 (en) Pyridone derivatives for the treatment of viral infections and other diseases
BR112014030288A8 (en) pharmaceutical composition, use thereof, and use of methanesulfonylacetonitrile
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL